A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity
Gespeichert in:
Verfasser / Beitragende:
[P.M. Ambuhl, A.C. Tissot, A. Fulurija, P. Maurer, J. Nussberger, R. Sabat, V. Nief, C. Schellekens, K. Sladko, K. Roubicek, T. Pfister, M. Rettenbacher, H. D. Volk, F. Wagner, P. Muller, G. T. Jennings, M. F. Bachmann]
Ort, Verlag, Jahr:
2007
Enthalten in:
Journal of Hypertension, 25/1(2007-01), 63-72
Format:
Artikel (online)